---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-028272"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T07:52:01.255838+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ApolloMed Q3 revenue up 40% to $317M; net income down to $26M; raises full-year guidance

## Summary
- Q3 revenue $317M (+40% YoY); net income $26M vs $34.3M; diluted EPS $0.56 vs $0.74.
- Adjusted EBITDA $57.1M (revised calculation) vs $62.9M prior year; nine-month revenue $850M (+47%).
- Closed acquisition of All American Medical Group (Oct 31) adding >15,000 members; acquired Valley Oaks Medical Group (9 clinics) serving 20,000 patients.
- Raised FY2022 revenue guidance to $1.095-1.115B, net income to $50.5-67M, EBITDA to $107.5-133.5M.

## SEC filing metadata
- accession: 0001628280-22-028272
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/0001628280-22-028272-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/ameh-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-028272
- JSON: https://secwatch.observer/filing/0001628280-22-028272.json
- Plain text: https://secwatch.observer/filing/0001628280-22-028272.txt

## Key facts
- Earnings Releases
  Astrana Health, Inc. reported nine months ended September 30, 2022 results: revenue $850.0 million, net income $51.6 million, EPS $1.12. Guidance raised.
  - Period: nine months ended September 30, 2022
  - Revenue: $850.0 million
  - Net income: $51.6 million
  - EPS: $1.12
  - Guidance: raised
  - Result: reported results
  source text: losses from recently acquired IPAs, which it believes to be more reflective of its business. Financial Highlights for Nine Months Ended September 30, 2022: • Total revenue of $850.0 million, up 47% from $578.8 million for the prior-year period • Net income attributable to ApolloMed of $51.6 million, compared to $60.1 million for the prior-year period • EPS-diluted
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/0001628280-22-028272-index.htm
- Earnings Releases
  Astrana Health, Inc. reported quarter ended September 30, 2022 results: revenue $317.0 million, net income $26.0 million, EPS $0.56. Guidance raised.
  - Period: quarter ended September 30, 2022
  - Revenue: $317.0 million
  - Net income: $26.0 million
  - EPS: $0.56
  - Guidance: raised
  - Result: reported results
  source text: financial results for the third quarter and nine months ended September 30, 2022. Financial Highlights for Third Quarter Ended September 30, 2022: • Total revenue of $317.0 million, up 40% from $227.1 million for the prior-year quarter • Net income attributable to ApolloMed of $26.0 million, compared to $34.3 million for the prior-year quarter • Earnings
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000162828022028272/0001628280-22-028272-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.